Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 33

1.

A long-term prospective study of type-specific human papillomavirus infection and risk of cervical neoplasia among 20,000 women in the Portland Kaiser Cohort Study.

Schiffman M, Glass AG, Wentzensen N, Rush BB, Castle PE, Scott DR, Buckland J, Sherman ME, Rydzak G, Kirk P, Lorincz AT, Wacholder S, Burk RD.

Cancer Epidemiol Biomarkers Prev. 2011 Jul;20(7):1398-409. doi: 10.1158/1055-9965.EPI-11-0206. Epub 2011 May 20. Erratum in: Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1390-1.

PMID:
21602310
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Persistence of human papillomavirus infection: keys to malignant progression.

Bodily J, Laimins LA.

Trends Microbiol. 2011 Jan;19(1):33-9. doi: 10.1016/j.tim.2010.10.002. Epub 2010 Nov 1. Review.

PMID:
21050765
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Screening: HPV testing for cervical cancer: the good, the bad, and the ugly.

Castle PE.

Nat Rev Clin Oncol. 2010 Jul;7(7):364-5. doi: 10.1038/nrclinonc.2010.96. No abstract available.

PMID:
20592711
[PubMed - indexed for MEDLINE]
4.

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial.

Ronco G, Giorgi-Rossi P, Carozzi F, Confortini M, Dalla Palma P, Del Mistro A, Ghiringhello B, Girlando S, Gillio-Tos A, De Marco L, Naldoni C, Pierotti P, Rizzolo R, Schincaglia P, Zorzi M, Zappa M, Segnan N, Cuzick J; New Technologies for Cervical Cancer screening (NTCC) Working Group.

Lancet Oncol. 2010 Mar;11(3):249-57. doi: 10.1016/S1470-2045(09)70360-2. Epub 2010 Jan 18.

PMID:
20089449
[PubMed - indexed for MEDLINE]
5.

Biomarkers in cervical cancer.

Yim EK, Park JS.

Biomark Insights. 2007 Feb 7;1:215-25.

PMID:
19690652
[PubMed]
Free PMC Article
6.

Triage of women with equivocal or low-grade cervical cytology results: a meta-analysis of the HPV test positivity rate.

Arbyn M, Martin-Hirsch P, Buntinx F, Van Ranst M, Paraskevaidis E, Dillner J.

J Cell Mol Med. 2009 Apr;13(4):648-59. doi: 10.1111/j.1582-4934.2008.00631.x. Epub 2009 Jan 23.

PMID:
19166485
[PubMed - indexed for MEDLINE]
7.

New paradigms in cervical cancer prevention: opportunities and risks.

Ronco G, Giorgi Rossi P.

BMC Womens Health. 2008 Dec 17;8:23. doi: 10.1186/1472-6874-8-23. Review.

PMID:
19091066
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

New technologies in cervical cancer screening.

Gravitt PE, Coutlée F, Iftner T, Sellors JW, Quint WG, Wheeler CM.

Vaccine. 2008 Aug 19;26 Suppl 10:K42-52. doi: 10.1016/j.vaccine.2008.05.002. Review.

PMID:
18847556
[PubMed - indexed for MEDLINE]
9.

Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later.

Sawaya GF.

Ann Intern Med. 2008 Apr 1;148(7):557-9. No abstract available.

PMID:
18378951
[PubMed - indexed for MEDLINE]
10.

Cervical cancer screening.

Partridge EE, Abu-Rustum N, Campos S, Fahey PJ, Greer BE, Lele SM, Lieberman RW, Lipscomb GH, Morgan M, Nava ME, Reynolds RK, Singh DK, Smith-McCune K, Teng N, Trimble CL, Valea F, Wilczynski S; National Comprehensive Cancer Network.

J Natl Compr Canc Netw. 2008 Jan;6(1):58-82. No abstract available.

PMID:
18267060
[PubMed - indexed for MEDLINE]
11.

Cellular binding partners of the human papillomavirus E6 protein.

Tungteakkhun SS, Duerksen-Hughes PJ.

Arch Virol. 2008;153(3):397-408. doi: 10.1007/s00705-007-0022-5. Epub 2008 Jan 3. Review.

PMID:
18172569
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Risk assessment to guide the prevention of cervical cancer.

Castle PE, Sideri M, Jeronimo J, Solomon D, Schiffman M.

Am J Obstet Gynecol. 2007 Oct;197(4):356.e1-6. Review.

PMID:
17904958
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Human papillomavirus testing and molecular markers of cervical dysplasia and carcinoma.

Dehn D, Torkko KC, Shroyer KR.

Cancer. 2007 Feb 25;111(1):1-14. Review.

PMID:
17219448
[PubMed - indexed for MEDLINE]
Free Article
14.

The natural history of cervical HPV infection: unresolved issues.

Woodman CB, Collins SI, Young LS.

Nat Rev Cancer. 2007 Jan;7(1):11-22. Review.

PMID:
17186016
[PubMed - indexed for MEDLINE]
15.

Chapter 9: Clinical applications of HPV testing: a summary of meta-analyses.

Arbyn M, Sasieni P, Meijer CJ, Clavel C, Koliopoulos G, Dillner J.

Vaccine. 2006 Aug 31;24 Suppl 3:S3/78-89. Review.

PMID:
16950021
[PubMed - indexed for MEDLINE]
16.

Cost-effectiveness of extending cervical cancer screening intervals among women with prior normal pap tests.

Kulasingam SL, Myers ER, Lawson HW, McConnell KJ, Kerlikowske K, Melnikow J, Washington AE, Sawaya GF.

Obstet Gynecol. 2006 Feb;107(2 Pt 1):321-8.

PMID:
16449119
[PubMed - indexed for MEDLINE]
17.

HPV-mediated cervical carcinogenesis: concepts and clinical implications.

Snijders PJ, Steenbergen RD, Heideman DA, Meijer CJ.

J Pathol. 2006 Jan;208(2):152-64. Review.

PMID:
16362994
[PubMed - indexed for MEDLINE]
18.

Regulation of apoptosis by the papillomavirus E6 oncogene.

Li TT, Zhao LN, Liu ZG, Han Y, Fan DM.

World J Gastroenterol. 2005 Feb 21;11(7):931-7. Review.

PMID:
15742391
[PubMed - indexed for MEDLINE]
Free Article
19.

Current cervical neoplasia screening practices of obstetrician/gynecologists in the US.

Saint M, Gildengorin G, Sawaya GF.

Am J Obstet Gynecol. 2005 Feb;192(2):414-21.

PMID:
15695980
[PubMed - indexed for MEDLINE]
20.

Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: A 2-year follow-up of women with ASCUS or LSIL Pap smear.

Molden T, Nygård JF, Kraus I, Karlsen F, Nygård M, Skare GB, Skomedal H, Thoresen SO, Hagmar B.

Int J Cancer. 2005 May 10;114(6):973-6.

PMID:
15645423
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk